About this item:

22 Views | 11 Downloads

Author Notes:

Correspondence: Albert J. Chang, MD, PhD, Department of Radiation Oncology, University of California, Los Angeles, 200 UCLA Medical Plaza, Ste B265, Los Angeles, CA 90095 (ajchang@mednet.ucla.edu)

Author Contributions: Dr Chang had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Concept and design: Nguyen, Lee, Patel, Kishan, Chang. Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Nguyen, Patel, Chakravorty, Chang. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Nguyen, Chakravorty, Chang. Administrative, technical, or material support: Nguyen, Chang. Supervision: Lee, Chang.

Disclosures: Dr Yu reported receiving personal fees from Boston Scientific and personal fees from Galera Pharmaceuticals outside the submitted work.

Dr Kishan reported receiving personal fees from Varian Medical Systems, grants and personal fees from ViewRay, Inc, and personal fees from Janssen outside the submitted work. No other disclosures were reported.


Research Funding:

None declared


  • Science & Technology
  • Life Sciences & Biomedicine
  • Medicine, General & Internal
  • General & Internal Medicine

Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer


Journal Title:

JAMA Open Network


Volume 3, Number 9


, Pages e2017144-e2017144

Type of Work:

Article | Final Publisher PDF


This cohort study examines trends in the use of brachytherapy, external beam radiotherapy, and stereotactic body radiation therapy for disease management in patients with localized prostate cancer and compares outcomes between these therapies.

Copyright information:

© 2020 Nguyen KA et al. JAMA Network Open.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote